Home Cart Sign in  
Chemical Structure| 81840-15-5 Chemical Structure| 81840-15-5

Structure of Vesnarinone
CAS No.: 81840-15-5

Chemical Structure| 81840-15-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vesnarinone is a PDE3 inhibitor with IC50 value of 1.1μM for inhibiton of HERG current.

Synonyms: OPC-8212

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vesnarinone

CAS No. :81840-15-5
Formula : C22H25N3O4
M.W : 395.45
SMILES Code : O=C1NC2=C(C=C(N3CCN(C(C4=CC=C(OC)C(OC)=C4)=O)CC3)C=C2)CC1
Synonyms :
OPC-8212
MDL No. :MFCD00867124
InChI Key :ZVNYJIZDIRKMBF-UHFFFAOYSA-N
Pubchem ID :5663

Safety of Vesnarinone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03217955 Psychotic Disorders Not Applicable Completed - -
NCT01494285 Acne Vulgaris Phase 1 Phase 2 Completed - Israel ... More >> HaEmek Medical Center Afula, Israel Meir Medical Center Kfar Saba, Israel Souraski Medical Center Tel Aviv, Israel Less <<
NCT03203044 Gut Microbiota Not Applicable Completed - -
NCT00002131 Sarcoma, Kaposi|HIV Infections PHASE2 COMPLETED - UCLA School of Medicine, Los A... More >>ngeles, California, 900121973, United States|Northwestern Univ Med School, Chicago, Illinois, 60611, United States Less <<
NCT00002130 HIV Infections COMPLETED - UCLA School of Medicine, Los A... More >>ngeles, California, 900121973, United States|AIDS Research Consortium of Atlanta, Atlanta, Georgia, 30308, United States Less <<
NCT00002337 HIV Infections PHASE1 COMPLETED - AIDS Research Consortium of At... More >>lanta, Atlanta, Georgia, 30308, United States Less <<
NCT00002129 HIV Infections PHASE1 COMPLETED - UCLA School of Medicine, Los A... More >>ngeles, California, 900121973, United States Less <<
NCT01431235 Attention Deficit Hyperactivit... More >>y Disorder Substance Use Disorders Less << Not Applicable Completed - Netherlands ... More >> Arkin Amsterdam, Netherlands Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.53mL

0.51mL

0.25mL

12.64mL

2.53mL

1.26mL

25.29mL

5.06mL

2.53mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories